CURRICULUM VITAE
Education:
Herbert H. Lehman College, NYC B.A. 1969 Anat/Phys.
Herbert H. Lehman College, NYC M.S. 1972 Molec/Biochem.
City University of New York, NYC Ph.D 1980 Molec/Biochem
Professional Experience
Chairman Biology Dept. University of Colorado CS 9/01-9-05
Associate Processor University of Colorado CS 9/01-present
Visiting Professor University of California (CME) 2006
Visiting Professor University of Virginia (CME) 2004
Director LCCRO Monoclonal Facility 1/93-2001
Assistant Research Professor Univ. of Vermont 8/88-2001
Assistant Research Professor N.Y. Medical College 1985-8/88
Research Associate N.Y. Medical College 1978-1981
Graduate Fellow Lehman College 1975-1978
Adjunct Lecturer Lehman College 1970-1975
Part-time Lecturer Bronx Comm. College 1970
Refereed Publications
1. Melamede, R. J. (2006). Endocannabinoids: Multi-scaled, Global Homeostatic Regulators of Cells and Society
. Abstract Paper #70. Proceedings of the
Sixth International Conference on
Complex Systems
2. Melamede, R. J. (2005). Harm reduction-the cannabis paradox. Harm Reduct J, 2(1), 17.
3. Melamede, R. J. (2005). Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J, 2, 21.
4. Newell, M.K., Melamede, R..J, Villalobos-Menuey, E., Swartzendruber, D., Trauger, R., Camley, R.E., Crisp, W. (2004), The Effects of Chemotherapeutics on Cellular Metabolism and Consequent Immune Recognition. Journal of Immune Based Therapies Vaccines. 2004 Feb 2;2(1):3. Epub 2004 Feb 02.
5. Harper M.-E., Antoniou A., Villalobos-Menuey, E., Russo, A., Trauger, R., Vendemelio M., Bartholemew R., Carlo D., Shaikh, A., Kupperman J., Newell E.W., Bespalov I. Wallace S.S., Liu,Y., Rogers, J.R., Gibbs, G.L., Leahy, J.L., Camley, R., Melamede, R.J., and Newell M.K. (2002). Characterization of a Novel Metabolic Strategy Used by Drug-resistant Tumor Cells. Federation of American Societies for Experimental BiologyJ. 16. 1550-1557. R. E.
6. Melamede R.J. (2002). Dissipative Structures and the Origins of Life. epub New England Complex Systems Institute, #604
7. Persinger, R.L., Melamede, R.J., Bespalov, I., Wallace, S., Taatjes, D.J., Janssen-Heininger, Y. (2001). Imaging techniques used for the detection of 8-oxoguanine adducts and DNA repair proteins in cells and tissues. Experimental Gerontology 2001 Sep;36 (9):1483-94.
8. Potts, R.J., Bespalov, I.A., Wallace, S.S., Melamede, R.J., and Hart, B.A. (2001). Inhibition of Oxidative DNA Repair in Cadmium-Adapted Alveolar Epithelial Cells. Toxicology. 2001 Mar 21;161(1-2):25-38.
9. Soultanakis, RP, Melamede, RJ, Bespalov, I., Wallace, S.S., Beckman, K, Ames B, Taatjes, D.J., and Janssen-Heininger YMW (2000). Fluorescent Detection of 8-oxogaunine in Nuclear and Mitochondrial DNA using the Mouse Monoclonal Fab 166 and Confocal Scanning Laser Microscopy in Cultured Cells. Radical Biology and Medicine 28 (6) 987-998.
10. Bespalov, I., Bond,J., Purmal, A.A. Wallace, S.S. and Robert J. Melamede. (1999). Fabs Specific For 8-Oxoguanine: Control of DNA Binding. Journal of Molecular Biology 293, (5), 1085-1095.
11. Stephenson, A.E., Fives-Taylor, P. and Melamede, R.J. (1998). Cell-based Panning as a Means to Isolate Phage Display Fabs Specific for a Bacterial Surface Protein. Methods in Cell Science. 20:241-249.
12. Jiang, D., Hatahet, Z., Melamede, R.J., and Wallace, S.S. (1997). Characterization of Escherichia coli endonuclease VIII. Journal of Biochemistry. 272:51:32230-32239.
13. Jiang, D., Hatahet, Z., Blaisdell, J.O., Melamede, R.J. and Wallace S.S. (1997). Escherichia coli endonuclease VIII: cloning, sequencing, and overexpression of the nei structural gene and characterization of nei and nei nth mutants. .Journal Bacteriology. 1997 Jun;179 (11):3773-3782.
14. Bespalov, I.A., Purmal, A.A., Bond, J., Wallace, S.S. and Melamede, R.J. (1997). Altering the Specificity of Hapten Binding Fabs that Recognize DNA Base Modifications. In Antibody Engineering: New Technology, Application & Commercialization.International Business Communication. 5.12:181-198
15. Bespalov, I.A., Purmal, A.A., Glackin, P.M., Wallace, S.S. and Melamede, R.J. (1996). Recombinant Phabs Reactive with 7,8,-Dihydro-8-oxoguanine, a Major Oxidative DNA Lesion. Biochemistry 35:2067-2078.
16. Landau, S.B., Aziz, W.I., Woodcook-Mitchell and Melamede R.J. (1995).V(I) Expression in Human Intestinal Lymphocytes is Restricted and Preferentially Utilizes V4. Immunological Investigations 24(6):947-955.
17. Yao, M., Hatahet, Z., Melamede, R.J. and Kow, Y.W.(1994). Purification and Characterization of a Novel Inosine Specific Enzyme, Inosine 3' Endonuclease from Escherichia coli Journal of Biochemistry. 269:16260-16268.
18. Purmal, A.A., Lampman, G.W., Pourmal, E., I., Melamede, R.J., Wallace. S.S. and Kow, Y.W. (1994). Uracil DNA N-glycosylase distributively interacts with duplex polynucleotides containing repeating units of either TGGCCAAGCU or TGGCCAAGCTTGGCCAAGCU. Journal of Biochemistry.. 269:22046-22053.
19. Melamede, R.J., Zafer Hatahet, Kow, Y.W., Ide, H. and Wallace, S.S. (1994). Isolation and Characterization of Endonuclease VIII from Escherichia Coli Biochemistry 33:1255-1264.
20. Schaeffer, W.I. and Melamede, R.J. (1992). Fluorometric Quantitation of Broth Cultured Mycoplasmas using Alkaline Ethidium Bromide. Clinical Microbiology 31(5):1303-1307
21. Kow, W.K., Faundez, G., Melamede, R.J. and Wallace, S.S. (1991). Processing of Model Single Stranded Breaks in OX-174 RF Transfecting DNA by Escherichia Coli Radiation Research. 1991 Jun;126(3):357-366.
22. Gulwani, B. Imberti, L., Maio, M., Melamede, R.J., and Ferrone, S. (1987). Immunosuppresive activity of T cell clones generated from human T cells stimulated with autologous T PHA cells. J. Immunology. 139:2130 2136.
23. Ide, H., Melamede, R.J. and Wallace, S.S. (1987). Synthesis of dihydrothymidine and thymine glycol triphosphates and their ability to serve as substrates for Escherichia coli DNA polymerase I. Biochemistry 26:964-969.
24. Rajagopalan, R., Melamede, R.J., Laspia, M.F., Wallace, S.S. and Erlanger, B.F. (1984). Properties of antibodies to thymine glycol, a product of the radiolysis of DNA. Radiation Research. 97:499-510.
25. Melamede, R.J. and Wallace, S.S. (1983). Incorporation of thymine containing DNA precursors in plasmolysed cells infected by the T4 non lethal recombination defective mutants I. Molecular and General Genetics. 191:382-388.
26. Melamede, R.J. and Wallace, S.S. (1983). Incorporation of thymine containing DNA precursors in plasmolysed cells infected by the T4 non lethal recombination defective mutants II. Molecular and General Genetics. 191:389-392.
27. Melamede, R.J. and Wallace, S.S. (1980). Phenotypic differences among the alleles of the T4 recombination defective mutants. Molecular and General Genetics. 179:327-330.
28. Melamede, R.J. and Wallace, S.S. (1980). Studies on the non lethal recombination repair deficient mutants of bacteriophage T4. III DNA replicative intermediates and T4w. Molecular and General Genetics. 177:501.
29. Melamede, R.J. and Wallace, S.S. (1978). The effect of exogenous deoxyribonucleosides on thymidine incorporation in T4 infected cells. Federation of European Biochemist. Letters 87:12-16.
30. Melamede, R.J. and Wallace, S.S. (1977). Studies on the non lethal recombinational repair deficient x and y mutants of bacteriophage T4. II DNA synthesis. Journal of Biochemistry. 24:28-40.
31. Wallace, S.S. and Melamede, R.J. (1972). Host and phage mediated repair of radiation damage in bacteriophage T4. Journal of Virology. 18:1159-1169.
Non-Refereed Publications:
Abstracts.
1. Melamede, R.J. (2007). Are Parry-Romberg’s Syndrome Patients Deficient In Endocannabinoid Activity? CB2 Receptors Conference Banff
2. Stubbs, C.E., Port, M., Newell, N.K., and Melamede, R.J. (2006). Lipid Metabolism, Cannabinoids and Cancer Therapy, BioSymposia .
3. Port, M., Stubbs, C.E., Newell, N.K., and Melamede, R.J. (2006). Base Excision Repair Gene Expression in U937 and RU937 Lymphoma Cells, , BioSymposia.
4. Melamede, R.J. (2005). “Medical Marijuana Can Help Biochemical Balance,” O’Shaughnessey, Medical Newsletter, Spring .
5. Melamede, R.J. (2005). “Medical Marijuana: Can help biochemical balance: nature’s solution for inflammatory pain,” Cannabis Health Vol 3, issue 3.
6. Stubbs, C.E., Port, M., Newell, N.K., and Melamede, R.J. "Metabolic and DNA Repair Enzyme Differences in the Hematapoetic Cell Lines HL60 and MDR," LAS Undergraduate Research Forum, 04/30/2005.
7. Port, M. Stubbs, C.E., Newell, N.K., and Melamede, R.J. "HLA Class I Expression in Drug Sensitive and Drug Resistant Tumor Cells," LAS Undergraduate Research Forum, 04/30/2005.
8. Schweitzer S., Barton S., Newell M.K., and Melamede R.J. (2003). Colorado Policy Institute. Can Cannabinoids Protect Cells From the Harmful Effects of Excess Sugar Consumption?
9. Fields, D.and Melamede R.J. (2003), American Association for the Advancement of Science (AAAS). Entropomic Space.
10. Fields, D. and Melamede R.J. (2002), Butcher Symposium Open System Far From Equilibrium Thermodynamics Suggests the Need to Use Entropomic Space
11. Nakae Y, Stoward PJ, Bespalov IA, Melamede RJ, Wallace SS. (2002) A new technique for the quantitative assessment of 8-oxoguanine in nuclear DNA as a marker of oxidative stress. Application to dystrophin-deficient DMD skeletal muscles. Histochem Cell Biol. 2002 Aug 10;:1-11
12. Melamede, R.J. (2002) The Costs of Marijuana Prohibition Colorado Policy Institute.
13. Melamede R.J. and Newell, M.K. (2002), Coleman Institute. Does the Endocannabinoid System Interact with UCP-2 to Protect or Kill Cells?
14. Melamede R.J. and Newell M.K. (2001), Coleman Institute. The Role of Endogenous Cannabinoids in Controlling the Life, Death and Differentiation of Nerve Cells.
15. Bespalov I.A., Purmal A.A., Wallace S.S., and Melamede R.J. Engineering antibodies that bind thymine glycol in DNA, (2001) In The Twelfth Annual International Conference on Antibody Engineering. International Business Communications
16. Bespalov, I., Purmal, A., Bond, J., Wallace, S.S., and Melamede, R.J. (1998) Engineering of Fabs Specific for 8-Oxoguanine in DNA. In The Ninth Annual International Conference Antibody Engineering. International Business Communications
17. Stephenson, A., Melamede, R.J., Mintz, K., and Fives-Taylor, P. (1997) Phage Display Monoclonal Antibodies to Adhesin Epitopes of S. sanguis Fap1 Protein. Journal of Dental Research 76:297.
18. Bespalov, I., Purmal, A., Bond, J., Wallace, S.S., and Melamede, R.J. (1996).Altering the Specificity of Hapten Binding Fabs that Recognize DNA Base Modifications In Antibody Engineering: New Technology, Application & Commercialization. International Business Communications.
19. Bespalov, I., Purmal, A., Glackin, M.P., Wallace, S.S., and Melamede, R.J. (1995). Recombinant Fabs Reactive with Oxidative DNA Lesions In Antibody Engineering: New Technology, Application & Commercialization.International Business Communications.
20. Landau, S.B., Aziz, W.I., Woodcook-Mitchell and Melamede R.J.(1995). V2,3,4, and 8 are Expressed by Human GD Intestinal Lymphocyte
21. Melamede, R.J. (1995). Human Leukocytic Antigen (HLA) Class I Presentation of DNA Repair Genes:Diagnostic and Therapeutic Targents Journal of Cellular Biochemistry supplement 19C .
22. Melamede, R.J., Purmal, A.A., Chen, B.-X., Connelly, G., Kow, Y.W., Erlanger, B., and Wallace, S.S. (1993). E. coli monoclonal antibodies to oxidative DNA damages. The New York Academy of Sciences, DNA Damage: Effects on DNA Structure and Protein Recognition, Burlington, Vermont, p11.
23. Glackin, M.P., Melamede, R.J., Kow, Y.K., and Wallace, S.S. (1992). Molecular Modeling of Base Lesion Inteteractions in the I-d Region of Escherichia coli LacI Gene Computational Approaches to Nucleic Acid Structure and Function.
24. Schaeffer, W.I., Simkins, S., Wilson, J. and Melamede, R.J. (1992). Fluorometric Quantitation of Broth Cultured Mycoplasmas. Proceedings of the International Organization for Mycoplasmology Meeeting, IOM Letters, Vol 2 pg. 218.
25. Melamede, R.J., Kow, Y.W., Ide, H. and Wallace, S.S. (1989). Novel Repair Endonucleases in E. Coli: Endonucleases VIII and IX. J. Cell. Biochem. supp.
26. Kow, Y.W., Ide, H., Melamede, R.J. and Wallace, S.S. (1988) Comparative study of the mechanisms of action of the apurinic endonucleases of Escherichia coli. J. Cell. Biochem. supp. 12A.
27. Ide, H., Kow, Y.W., Melamede, R.J. and Wallace S.S. (1988). Specificity of DNA N glycosylase activities of endonucleases III, VIII and IX. J. Cell. Biochem. supp. 12A.
28. Wallace, S.S., Ide, I., Kow, Y.K., Laspia, M.F.,LeClerc, E.J., Melamede, R.J. and Petrullo, L.A. (1988). Processing of oxidative DNA base damage in Escherichia coli. J. Cell. Biochem. supp. 12A.
29. Melamede, R.J., Kow, Y.W. and Wallace, S.S. (1988). Escherichia coli Endonuclease VIII and Endonuclease IX: substrate specificity and identification of damages. J. Cell. Biochem. supp. 12A.
30. Gulwani, B. Imberti, L., Maio, M., Melamede, R.J., and Ferrone, S. (1987). T Cell Clones Generated From Human T Cells Stimulated With Autologous T PHA Cells Display An Immunosupressive Avtivity. Abs International Symposium on Biotechnology in Clinical Medicine, Rome, Italy.
31. Melamede, R.J., Kow, Y.. and Wallace, S.S. (1987). Isolation and purification of a novel activity from Escherichia coli that recognizes thymine glycol. Abs. 2nd International Conference on Anticarcinogenesis and Radiation Protection, Gaithersburg, MD., VI 5.
32. Ide, H., Melamede, R.J., Kow, Y.W. and Wallace, S.S. (1987). Incorporation of dihydrothymidine triphosphate during DNA replication: An implication for the biological consequence of thymine C5 C6 bond saturation. Abs. 2nd International Conference on Anticarcinogenesis and Radiation Protection, Gaithersburg, MD, VI 4.
33. Hubbard, K., Kow, Y.W., Ide, H., Melamede, R.J. and Wallace, S.S. (1987). Quantitation of thymine radiolysis products in DNA X irradiated in vitro. Abs. 35th Annual Meeting of the Radiat. Res. Society, Atlanta, Georgia, p. 98.
34. Melamede, R.J. and Wallace, S.S. (1985). Sodium bisulfite produces DNA damage distinguishable by Escherichia coli repair endonuleasess. Abs. International Conference on the Mechanisms of DNA Damage and Repair, Gaithersburg, MD.
35. Melamede, R.J. and Wallace, S.S. (1983). A possible secondary role for thymine containingDNA precursors. Conference on the Genetic Consequences of Nucleotide Pool Imbalance, Research Tringle Park, North Carolina.
36. Wallace, S.S., Melamede, R.J., Laspia, M.F., Rajagopalan, R. and Erlanger, B.F. (1983). Immunochemical detection of radiation induced base lesion in DNA. J. Cell. Biochem. Suppl. 7B:173.
37. Rajagopalan, R.J., Laspia, M.F., Melamede, R.J., Wallace, S.S. and Erlanger, B.F. (1982). Some chemical and immunochemical studies on radiation modified thymidine. Abs. International Workshop on Immune Assay of Nuclear Antigens Relevant to Carcinogenesis and Chemotherapy, Manchester, England.
38. Melamede, R.J. and Wallace, S.S. (1981). Incorporation of thymine containing DNA precursors in T4 infected plasmolysed cells. Abs. 3rd Evergreen International T4 Meeting, Olympia, Washington
39. Wallace, S.S. and Melamede, R.J. (1980). Properties of the T4 recombination repair defective mutants. Abs. 2nd Evergreen T4 Meeting, Olympia, Washington.
40. Wallace, S.S. and Melamede, R.J. (1979). DNA synthesis in T4 infect plasmolysed cells: Effects of the non-lethal recombination gene products. Fed. Proc. 38:489.
41. Melamede, R.J. and Wallace, S.S. (1978). T4 induced recombination repair. Supramolec. Struc., Suppl. 2:64.
42. Melamde, R.J. and Wallace, S.S. (1977). Aberrant DNA intermediates in cells infected with the recombination deficient x and y mutants of bacteriophage T4. Biophys. J. 17:286a.
43. Melamede, R.J. and Wallace, S.S. (1974). DNA synthesis in T4 and its repair deficient mutants. Fed. Proc. 33:1600.
Chapters:
1. Melamede, R.J. invited Endocannabinoids: Marijuana from Within, chapter for fall 2007. Manucript in preparation.
2. Melamede, R.J. Indications for Cannabinoids: Autoimmune Diseases, in CANNABIS and CANNABINOIDS, Pharmacology, Toxicology and Therapeutic Potential, Haworth Press (U.S) April, 2002.
3. Melamede, R.J. Indications for Cannabinoids: Autoimmune Diseases, in Cannabis und Cannabinoide. Pharmakologie, Toxikologie und Therapeutisches Potential. Huber-Verlag (Bern),January, 2001
4. Melamede R.J. Cannabis-whether we like it of not. Chemistry and Industry. November 21, 2001 p.724
5. Lipton, L.E. and Melamede R.J.. 'Organizational Learning: The Essential Journey.' In "The Process-Centered School: Sustaining a Renaissance Community," (1997) edited by Arthur L. Costa and Rosemarie M.
6. Melamede, R.J., Kow, Y.W. and Wallace, S.S. Detection of oxidative DNA base damages: Immunochemical and electrochemical approaches. (1996) Technologies for Detection of DNA Damage and Mutations. Gerd P. Pfeifer, Ed., Plenum Press
7. Wallace,S.S., Ide, H., Kow, Y.W., Laspia, M.L., Melamede, R.J., Petrullo, L.A. and LeClerc, E. (1988). Processing of oxidative DNA base damages in Escherichia coli. In Mechanisms and Consequences of DNA Damage Processing. Alan Liss, New York.
8. Melamede, R.J., Kow, Y.W. and Wallace, S.S. (1988). The isolation and preliminary characterization of endonuclease VIII from Escherichia coli, In: "Anticarcinogenesis and Radiation Protection", (F. Nygaard, Simic and P. Cerutti, eds.), Plenum Press, NY.
9. Melamede, R.J. and Wallace, S.S. (1985). "A possible secondary role of thymine containing DNA precursors," in The Genetic Consequences of Nucleotide Pool Imbalance, F. de Serres, ed., Basic Life Science Series, Plenum Press, N,Y., p. 67-102.
OnLine Video presentations
http://www.veoh.com/static/flash/players/videodetails.swf?player=videodetails&type=v&permalinkId=0d2eb78a229d98366138f2dbf37f244c93cff856&version=4
http://video.google.com/videoplay?docid=-2483576733594576579
Published Letters:
Journals
1. Melamede R.J. (23 May 2003) British Medical Journal, A Science Based Evaluation of Cannabis and Cancer http://bmj.com/cgi/eletters/326/7396/942#31878
Newspapers:
1. Feds do their Best to Perpetuate Myth, Fri, 16, Feb 2007 Gazette, The (Colorado Springs, CO)
2. Reefer Madness Sun, 10, Sept 2006 Gazette, The (Colorado Springs, CO)
3. Senseless War, Sun, 01 Jan 2006 Gazette, The (Colorado Springs, CO)
4. Medical Marijuana Allard Ignores Legalization Benefits Gazette, The (Colorado Springs, CO) Apr 2004.
5. Amendment Could Enable Patients to Avoid Opiates Gazette, The (Colorado Springs, CO) 19 Jun 2004
6. Marijuana Is A Miracle, Rocky Mountain News (Denver, CO) 18 Dec 2003
7. Our Bodies Make, Use 'Pot'-Like Compounds Source: Rocky Mountain News (Denver, CO) 20 Jun 2003
8. Medical Marijuana Racine Journal Times, The (WI) 05 May 2003
9. Alternative Medicine? MARIJUANA CAN TREAT MANY DISEASES Source: Gazette, The (CO) 16 Apr 2003
10. Believe The Scientists And Patients Who Suffer Source: Ocean County Observer (NJ) 14 Apr 2003
11. Ignorant Doctors Boulder Weekly (CO) 6 Feb 2003
12. Heed The Science Denver Post (CO) Fri, 08 Nov 2002
13. Get Educated On The Benefits Of Marijuana Las Vegas City Life (NV) Thu, 31 Oct 2002
14. Mind-Alteration Daily Camera (CO) 27 Feb 2002
15. DEA's Crackdown Doesn't Make Scientific Sense Athens News, The (OH) 17 Jan 2002
A Sample of Articles Resulting from Melamede’s Scientific Publications:
1. WebMD http://www.foxnews.com/story/0,2933,196678,00.html
2. Marijuana Links to Cancer Going Up In Smoke, Fri, 29 Oct 2005 Sydney Morning Herald (Australia)
3. Pot Has Little Cancer Risk Sun, 23 Oct 2005 Indianapolis Star (IN).
4. Science Needed, Aldergrove Star (CN BC) 12 Aug.
5. Marijuana Less of a Cancer Risk Than Tobacco, Study Wed, 19 Oct 2005 Chronicle Herald (CN NS).
6. Less Cancer Risk In Pot Than Tobacco, Says Study, Thu, 20 Oct 2005 Windsor Star (CN ON).
7. Pot Less of a Cancer Risk Than Tobacco, Study Suggests, Tue, 18 Oct 2005, Globe and Mail (Canada).
8. Cannabis Cancer Risk Played Down, Tue, 18 Oct 2005, 2005 BBC.
Invited Presentations at Professional Meetings and Seminars:
1. 2006 National Organization for the Reform of Marijuana Laws. San Francisco.
2. 2006 The Sixth International Conference on Complex Systems
3. 2006 Santa Fe, Drug Policy Alliance of New Mexico.
4. 2006 Santa Barbara Community College, Fourth National Clinical Conference on Cannabis Therapeutics (UCSF designates this activity for a maximum of 15.75 AMA PRA category 1 credits.
The approved credits include 6.5 credits toward meeting Pain Management and End-of-Life Care).
5. 2005 National Organization for the Reform of Marijuana Laws. San Francisco.
6. 2004 University of Virginia, The Third National Clinical Conference on Cannabis Therapeutics.
7. 2004 broadcast 90 minute lecture on KMUD Radio in Los Angeles.
8. 2003 Oakland Cannabis Buyers Club
9. 2003 Safe Access Now Hayden Ca
10. 2003 Lecture for Pillar (education in retirement)
11. 2001 Sigma Psi, University of Colorado
12. 2000 University of Texas at Tylor
13. 1998 Pentose Pharmaceuticals
14. 1997 Pyrosequencing (Sweden)
15. 1997 Morphosys (Germany)
16. 1996 Alteon
17. 1996 IDEXX Laboratories Inc.
18. 1995 Jefferson Cancer Center
19. 1995 Wellness Council of Upper Peninsula
20. 1993 Immune Response Corporation
21. 1985 1986 Beckman, Cetus, Dupont, LKB Pharmacia, Whitehead Institute
Meeting Attended and Presented Abstracts
1. CB2 2007
2. UCCS Undergraduate Research Symposium 2006
3. 16th International Antibody Engineering Conference 2005
4. Inaugural International Conference Protein Engineering 2005
5. Coleman Symposium 2005
6. UCCS Undergraduate Research Symposium 2005
7. American Association for the Advancement of Science 2003
8. Butcher Symposium 2002
9. Colorado Policy Studies 2002
10. Coleman Institute 2002
11. Coleman Institute 2001
12. Antibody Engineering Conference 2001
Grants and Research:
Principal Investigator
Automated Process for Sequencing Nucleotides and Site specific Mutagenesis,Whitehead Associates: Venture Capital Support
$90,000 11/84 86
Development Grant to establish in vitro antibody technology at UVM.
Vermont Cancer Center $75,000 12/92-12/93
$45,000 1/94/-12-94
Development Grant A Novel Method for Determining Antigens that bind T-cells. Immune Response Corporation $30,000 1/94-12/94
NISSC - Modulation of Homeostatic Mechanisms to Reduce Biological Consequences of Radiation Exposure $10,000 6/03-12/03
Biologically Motivated Personalized Computation Forms for Wearable Computing. (Dr. Semwal) NSF not funded $200,000 2/04
DNA Damages in Drug Resistant Cancer Cells Committee on Research and Creative Works $5,000 3/07
Co-Principle Investigator
An Immunological Approach to Study DNA Damage and Repair
DOE $780,000 3/1/97-11/30/98
Repair of DNA Damage Induced by Ionizing Radiation
NIH: $764,694 4/82 3/95
Research-based Computer-assisted Undergraduate Molecular Biology Labs. NSF: $90,447 1/93-1/95
Patents and Disclosures
1. Automatable Process For Sequencing Nucleotides 9/5/89 USA Patent #4,863,849 (sold to PyroSequencing 1998)
2. Fluorometric Quantitation Mycoplasma Bromide USA Patent # 5,604,096, 2/18/97
3. Disclosure, A means of preserving organs and tissue for transplant, and for improving the success of transplantation (Disclosed 6/02)
4. Disclosure, Diagnostic And Therapeutic Treatments Related To Mitochondreal Disorders PCT, (application pending 5/13/03)
5. Disclosure, A method for treating a curing psoriasis (6/13/03)
Reviewer-Grants/Manuscripts
National Science Foundation (pre 2001)
Connecticut Innovations Inc (pre 2001)
International Radiation Research Society (pre 2001)
Archives of Internal Medicine (2006)
Harm Reduction Journal (2006)
Gifts:
Monetary
$5,000 research gift Walter Weinstein (2006)
$20,000 research gift from Newellink (2005)
Arranged $40,000 Gift from Weinstein Family to Bioenergetics Institute (2004)
Equipment:
2004 ABI Automated DNA Sequencer (used)
2003 BioTeK Fluorescent Plate Reader (used)
2002 BioTek Spectrophotometric Plate Reader (used)
2001 Visible Genetics Sequencers (2) (used)
Founder-Newellink Corporation License agreement with CU brings in $180,000/yr for Dr. Newell’s research, additionally, CU and UVM receive annual licensing fees and will receive royalties.
Honors
Advisory Board of the IACM Journal (The Journal of the International Association for Cannabis as Medicine) 2006-present.
Scientific Advisory Board Medical Marijuana Policy Advocacy Project 2006-present.
Board of Directors-Newellink Inc 2005-present.
Scientific Advisory Board Americans for Safe Access 2005-present.
Scientific Advisory Board Sensible Colorado 2005-present.
Students:
UCCS Students
Undergraduate
Michael Collins – graduated 2004, Darus Bechamie graduated 2005, Rafael Vega graduated 2005, Chris Stubbs-graduated 2006, Jackie Hartley-graduated 2006, Mike Port- graduated 2006, Anna Strompolos- graduated 2006, Martin Michelon-graduated 2006, Joshua Caberra- graduated 2007, John Midkiff- graduated 2007.
Graduate Students
Steven Barton (left for med school),
Kathleen May (left for Newell lab and Osteopath school), Brad Storrs (graduated MBS), Maria McGee current, David Owens, Shady Eshak,
Masters Committee William Richardson, Cecilly Dupree, Amber Havermaule
Darah Evans. Brian Resnick, James Tillman, Alyson Andreasen , Fillip Mirzakhanov
Local High School Students
Karen Jones and Kristen Wells-received first place in regional Science Fair (2004), went on to the internationals and each received $45,000 scholarships for their cannabis and cancer project. In 2005 they place 4th in the regional science fair.
Courses:
Taught
Biol 203 Microbiology, Fall 2001-current, fall and spring semesters
Biol 400 (now Biol 408) Endocannabinoids and Medical Marijuana, fall and spring semesters fall 2002-current.
Biol 401 Spring, Fall 05, Springand Fall 2006, Fall 2007.
Biol 400 DNA Repair Spring 2006.
Guest Lecturer
Cell biology, Immunology, Advanced Immunology, Bioinfomatics,
Computer Science
Professional Organizations
American Association foe the Advancement of Science (AAAS)
Sigma Xi
International Cannabinoid Research Society, (ICRS)
International Association for Cannabis as Medicine, (IACM)
New England Complex System Institute, (NECSI)
Vermont Cancer Center
University of Colorado Center for Computational Biology
Service on-Campus:
Chairman Biology Department (2001-2005)
Director of MBS Program (2005)
NIH Institutional Review Committee (formerly Recombinant Research Committee, current)
Alternate member of IACUC (current)
Chairs Advisory Committee to the Dean (2001-2005)
LAS Dean’s Budget and Planning Committee (2003-2007)
LAS Dean’s Budget (2007-present)
LAS Dean’s Planning (2007-present)
LAS Dean’s Science Advisory Board (2001-2005)
Game Design and Development (2005-2007)
System – Committee on University Discoveries (2003-present)
Search Committee Dean of Education (2005)
Search Committee Exercise Science position (2005)
Search Committee Biochemistry Position (Biology Department) (2004-2005)
Search Committee Biochemistry Position (Chemistry Department, 2004)
Service off-Campus
8/19/07 presented to over 100,000 participants of Seattle Hempfest
8/1/07 Educational presentation to El Paso County Drug Task force
7/31/07 KBPI radio interview
4/25/07 Presentation to the Free Thinkers
4/20/07 KBPI radio interview
2/10/06 KBPI radio interview
1/19/06 Medical Marijuana podcast http://gslc.genetics.utah.edu
11/05 Interview Associated Press
11/05 Interview NBC News
11/05 Medical Advisory Board Americans for Safe Access (ASA)
10/05 Clearwater National Syndicated News interview
12/05 Board Member Sensible Colorado
4/30/05 Million Marijuana March Acasia Park
10/18/04 Café Scientifique
9/18/04 Back to the Bluffs UCCS
8/21/04 Dean Becker Radio Show-Cultural Baggage KPFT Houston Texas
5/1/04 Million Marijuana March Acasia Park
12/9/03 PILLAR Institute for Learning in Retirement
11/03 Radio Interview Jim Dexter Show Utah KTKK
10/4/03 Fallfest presentation
10/23/02 FreeThinkers
10/12/02 Luncheon at BSCS with Bruce Alperts President of National Academy of Sciences
10/2/02 Radio Interview Colleen Brookes Show Denver WKBI
9/28/02 UCCS Fall Fest
9/15/02 Acasia Park Hemp Rally
9/2/02 Radio Interview Jim Dexter Show Utah KTKK
08/17/02 Denver HempFest
3/20/02 Member of TriBeta Society
01/15/02 Judged Black Forrest Peyton Middle School Science Fair
Copyright Veterans for Medical Marijuana Access